The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Given the prevalence of managed care, it’s incumbent upon the industry to ensure that there is a robust supplier pool.

Oklahoma and South Carolina are among nine states that use some form of provider-based reference pricing to contain spending ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Paige Nong of the University of Minnesota about her recent paper that evaluates and explores the current use of artificial intelligence and ...

While evidence-based decisions are essential, they must be paired with effective public messaging that builds trust and ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

We examine key lessons on medical-dental integration from the Program of All-Inclusive Care for the Elderly (PACE), ...